Public health officials are sounding the alarm over a new class of synthetic opioids known as nitazenes. First developed in the 1950s as potential painkillers but never approved for medical use, nitazenes have reappeared on the illicit drug market. According to the U.S. Drug Enforcement Administration (DEA), some forms of nitazenes can be up to 40 times more potent than fentanyl, making them among the most dangerous synthetic opioids yet encountered.

The DEA reports that nitazenes have been found mixed into heroin, counterfeit pills, and other substances without the buyer’s knowledge. This hidden presence raises the risk of accidental overdose, especially among people who are unaware of their extreme potency. Because nitazenes are so strong, they can overwhelm even experienced opioid users and are more resistant to standard doses of naloxone, the medication used to reverse overdoses.

For Native American communities, the emergence of nitazenes is especially concerning. Indigenous people already face disproportionately high rates of opioid-related overdose deaths. In some states, Native Americans are several times more likely to die from opioid overdoses than white residents. These disparities stem from a complex mix of factors including limited access to healthcare, underfunded public health infrastructure, and the ongoing impact of historical trauma.

If nitazenes become more common in the drug supply, these existing disparities could widen. Many tribal communities are located in rural areas where emergency medical services are limited. The combination of a highly potent opioid and slower access to emergency care could be deadly. Moreover, if multiple doses of naloxone are needed to reverse a nitazene overdose, communities without steady supply lines for the medication will face additional challenges.

Awareness and preparedness will be key. The DEA urges law enforcement, healthcare providers, and harm reduction groups to test seized drugs and monitor for nitazenes. Public education campaigns in tribal communities could help raise awareness about the risks of unknown substances and the need to carry naloxone. Community health workers and first responders may also require updated training on recognizing and responding to nitazene overdoses.

While nitazenes remain less common than fentanyl for now, the speed with which synthetic opioids have spread in the past is a warning sign. Fentanyl went from a rare contaminant to the leading cause of overdose deaths in less than a decade. Experts fear nitazenes could follow a similar trajectory if proactive steps are not taken.

For Native American communities already navigating the devastating impact of the opioid crisis, the appearance of nitazenes represents a new and urgent threat. The most effective response will combine education, testing, treatment access, and emergency preparedness. By acting quickly, communities can strengthen their defenses before nitazenes take hold.

Source: U.S. Drug Enforcement Administration